Selected research
Market Structure
Global Biobanking LIMS Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biobanking LIMS Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Biobanking LIMS Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biobanking LIMS Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biobanking LIMS Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biobanking LIMS Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biobanking LIMS Software include Cell&Co BioServices, RUCDR LIMS, Csols, Agilent Technologies, CloudLIMS, LabCollector, OpenSpecimen, BSI Systems and TDBioBank, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Biobanking LIMS Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biobanking LIMS Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biobanking LIMS Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biobanking LIMS Software market size, projected growth trends, production technologies, key applications, and end-use industries.
Biobanking LIMS Software Segment by Company
Cell&Co BioServices
RUCDR LIMS
Csols
Agilent Technologies
CloudLIMS
LabCollector
OpenSpecimen
BSI Systems
TDBioBank
Autoscribe
LabVantage
Thermo Fisher Scientific
Ocimum Biosolutions
LabKey
Azenta US
Modul-Bio
LIMSABC
Biobanking LIMS Software Segment by Type
Cloud Based
On-Premise
Biobanking LIMS Software Segment by Application
Regenerative Medicine
Life Science
Clinical Research
Biobanking LIMS Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biobanking LIMS Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biobanking LIMS Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biobanking LIMS Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biobanking LIMS Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biobanking LIMS Software industry.
Chapter 3: Detailed analysis of Biobanking LIMS Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biobanking LIMS Softwarerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud Based
- On-Premise
Applications
- Regenerative Medicine
- Life Science
- Clinical Research
Companies covered
- Cell&Co BioServices
- RUCDR LIMS
- Csols
- Agilent Technologies
- CloudLIMS
- LabCollector
- OpenSpecimen
- BSI Systems
- TDBioBank
- Autoscribe
- LabVantage
- Thermo Fisher Scientific
- Ocimum Biosolutions
- LabKey
- Azenta US
- Modul-Bio
- LIMSABC
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Biobanking LIMS Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Cloud Based
- 1.2.3 On-Premise
- 1.3 Market Analysis by Application
- 1.3.1 Global Biobanking LIMS Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Regenerative Medicine
- 1.3.3 Life Science
- 1.3.4 Clinical Research
- 1.4 Global Market Growth Prospects
- 1.5 Global Biobanking LIMS Software Growth Trends by Region
- 1.5.1 Global Biobanking LIMS Software Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Biobanking LIMS Software Market Size by Region (2021-2026)
- 1.5.3 Biobanking LIMS Software Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Biobanking LIMS Software Market Dynamics
- 2.1 Biobanking LIMS Software Industry Trends
- 2.2 Biobanking LIMS Software Industry Drivers
- 2.3 Biobanking LIMS Software Industry Opportunities and Challenges
- 2.4 Biobanking LIMS Software Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Biobanking LIMS Software Revenue by Company (2021-2026)
- 3.2 Global Biobanking LIMS Software Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Biobanking LIMS Software Key Company Head office and Area Served
- 3.4 Global Biobanking LIMS Software Company, Product Type & Application
- 3.5 Global Biobanking LIMS Software Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Biobanking LIMS Software Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Biobanking LIMS Software Players Market Share by Revenue in 2025
- 3.6.3 2025 Biobanking LIMS Software Tier 1, Tier 2, and Tier 3
4 Biobanking LIMS Software Market by Type
- 4.1 Global Biobanking LIMS Software Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Biobanking LIMS Software Market Size by Type (2021-2032)
- 4.3 Global Biobanking LIMS Software Market Size Share by Type (2021-2032)
5 Biobanking LIMS Software Market by Application
- 5.1 Global Biobanking LIMS Software Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Biobanking LIMS Software Market Size by Application (2021-2032)
- 5.3 Global Biobanking LIMS Software Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Cell&Co BioServices
- 6.1.1 Cell&Co BioServices Company Information
- 6.1.2 Cell&Co BioServices Business Overview
- 6.1.3 Cell&Co BioServices Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Cell&Co BioServices Biobanking LIMS Software Product Portfolio
- 6.1.5 Cell&Co BioServices Recent Developments
- 6.2 RUCDR LIMS
- 6.2.1 RUCDR LIMS Company Information
- 6.2.2 RUCDR LIMS Business Overview
- 6.2.3 RUCDR LIMS Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 RUCDR LIMS Biobanking LIMS Software Product Portfolio
- 6.2.5 RUCDR LIMS Recent Developments
- 6.3 Csols
- 6.3.1 Csols Company Information
- 6.3.2 Csols Business Overview
- 6.3.3 Csols Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Csols Biobanking LIMS Software Product Portfolio
- 6.3.5 Csols Recent Developments
- 6.4 Agilent Technologies
- 6.4.1 Agilent Technologies Company Information
- 6.4.2 Agilent Technologies Business Overview
- 6.4.3 Agilent Technologies Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Agilent Technologies Biobanking LIMS Software Product Portfolio
- 6.4.5 Agilent Technologies Recent Developments
- 6.5 CloudLIMS
- 6.5.1 CloudLIMS Company Information
- 6.5.2 CloudLIMS Business Overview
- 6.5.3 CloudLIMS Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 CloudLIMS Biobanking LIMS Software Product Portfolio
- 6.5.5 CloudLIMS Recent Developments
- 6.6 LabCollector
- 6.6.1 LabCollector Company Information
- 6.6.2 LabCollector Business Overview
- 6.6.3 LabCollector Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 LabCollector Biobanking LIMS Software Product Portfolio
- 6.6.5 LabCollector Recent Developments
- 6.7 OpenSpecimen
- 6.7.1 OpenSpecimen Company Information
- 6.7.2 OpenSpecimen Business Overview
- 6.7.3 OpenSpecimen Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 OpenSpecimen Biobanking LIMS Software Product Portfolio
- 6.7.5 OpenSpecimen Recent Developments
- 6.8 BSI Systems
- 6.8.1 BSI Systems Company Information
- 6.8.2 BSI Systems Business Overview
- 6.8.3 BSI Systems Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 BSI Systems Biobanking LIMS Software Product Portfolio
- 6.8.5 BSI Systems Recent Developments
- 6.9 TDBioBank
- 6.9.1 TDBioBank Company Information
- 6.9.2 TDBioBank Business Overview
- 6.9.3 TDBioBank Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 TDBioBank Biobanking LIMS Software Product Portfolio
- 6.9.5 TDBioBank Recent Developments
- 6.10 Autoscribe
- 6.10.1 Autoscribe Company Information
- 6.10.2 Autoscribe Business Overview
- 6.10.3 Autoscribe Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Autoscribe Biobanking LIMS Software Product Portfolio
- 6.10.5 Autoscribe Recent Developments
- 6.11 LabVantage
- 6.11.1 LabVantage Company Information
- 6.11.2 LabVantage Business Overview
- 6.11.3 LabVantage Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 LabVantage Biobanking LIMS Software Product Portfolio
- 6.11.5 LabVantage Recent Developments
- 6.12 Thermo Fisher Scientific
- 6.12.1 Thermo Fisher Scientific Company Information
- 6.12.2 Thermo Fisher Scientific Business Overview
- 6.12.3 Thermo Fisher Scientific Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Thermo Fisher Scientific Biobanking LIMS Software Product Portfolio
- 6.12.5 Thermo Fisher Scientific Recent Developments
- 6.13 Ocimum Biosolutions
- 6.13.1 Ocimum Biosolutions Company Information
- 6.13.2 Ocimum Biosolutions Business Overview
- 6.13.3 Ocimum Biosolutions Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Ocimum Biosolutions Biobanking LIMS Software Product Portfolio
- 6.13.5 Ocimum Biosolutions Recent Developments
- 6.14 LabKey
- 6.14.1 LabKey Company Information
- 6.14.2 LabKey Business Overview
- 6.14.3 LabKey Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 LabKey Biobanking LIMS Software Product Portfolio
- 6.14.5 LabKey Recent Developments
- 6.15 Azenta US
- 6.15.1 Azenta US Company Information
- 6.15.2 Azenta US Business Overview
- 6.15.3 Azenta US Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 Azenta US Biobanking LIMS Software Product Portfolio
- 6.15.5 Azenta US Recent Developments
- 6.16 Modul-Bio
- 6.16.1 Modul-Bio Company Information
- 6.16.2 Modul-Bio Business Overview
- 6.16.3 Modul-Bio Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 Modul-Bio Biobanking LIMS Software Product Portfolio
- 6.16.5 Modul-Bio Recent Developments
- 6.17 LIMSABC
- 6.17.1 LIMSABC Company Information
- 6.17.2 LIMSABC Business Overview
- 6.17.3 LIMSABC Biobanking LIMS Software Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 LIMSABC Biobanking LIMS Software Product Portfolio
- 6.17.5 LIMSABC Recent Developments
7 North America
- 7.1 North America Biobanking LIMS Software Market Size (2021-2032)
- 7.2 North America Biobanking LIMS Software Market Size by Type
- 7.2.1 North America Biobanking LIMS Software Market Size by Type (2021-2026)
- 7.2.2 North America Biobanking LIMS Software Market Size by Type (2027-2032)
- 7.2.3 North America Biobanking LIMS Software Market Share by Type (2021-2032)
- 7.3 North America Biobanking LIMS Software Market Size by Application
- 7.3.1 North America Biobanking LIMS Software Market Size by Application (2021-2026)
- 7.3.2 North America Biobanking LIMS Software Market Size by Application (2027-2032)
- 7.3.3 North America Biobanking LIMS Software Market Share by Application (2021-2032)
- 7.4 North America Biobanking LIMS Software Market Size by Country
- 7.4.1 North America Biobanking LIMS Software Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Biobanking LIMS Software Market Size by Country (2021-2026)
- 7.4.3 North America Biobanking LIMS Software Market Size by Country (2027-2032)
- 7.4.4 North America Biobanking LIMS Software Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Biobanking LIMS Software Market Size (2021-2032)
- 8.2 Europe Biobanking LIMS Software Market Size by Type
- 8.2.1 Europe Biobanking LIMS Software Market Size by Type (2021-2026)
- 8.2.2 Europe Biobanking LIMS Software Market Size by Type (2027-2032)
- 8.2.3 Europe Biobanking LIMS Software Market Share by Type (2021-2032)
- 8.3 Europe Biobanking LIMS Software Market Size by Application
- 8.3.1 Europe Biobanking LIMS Software Market Size by Application (2021-2026)
- 8.3.2 Europe Biobanking LIMS Software Market Size by Application (2027-2032)
- 8.3.3 Europe Biobanking LIMS Software Market Share by Application (2021-2032)
- 8.4 Europe Biobanking LIMS Software Market Size by Country
- 8.4.1 Europe Biobanking LIMS Software Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Biobanking LIMS Software Market Size by Country (2021-2026)
- 8.4.3 Europe Biobanking LIMS Software Market Size by Country (2027-2032)
- 8.4.4 Europe Biobanking LIMS Software Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Biobanking LIMS Software Market Size (2021-2032)
- 9.2 China Biobanking LIMS Software Market Size by Type
- 9.2.1 China Biobanking LIMS Software Market Size by Type (2021-2026)
- 9.2.2 China Biobanking LIMS Software Market Size by Type (2027-2032)
- 9.2.3 China Biobanking LIMS Software Market Share by Type (2021-2032)
- 9.3 China Biobanking LIMS Software Market Size by Application
- 9.3.1 China Biobanking LIMS Software Market Size by Application (2021-2026)
- 9.3.2 China Biobanking LIMS Software Market Size by Application (2027-2032)
- 9.3.3 China Biobanking LIMS Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Biobanking LIMS Software Market Size (2021-2032)
- 10.2 Asia Biobanking LIMS Software Market Size by Type
- 10.2.1 Asia Biobanking LIMS Software Market Size by Type (2021-2026)
- 10.2.2 Asia Biobanking LIMS Software Market Size by Type (2027-2032)
- 10.2.3 Asia Biobanking LIMS Software Market Share by Type (2021-2032)
- 10.3 Asia Biobanking LIMS Software Market Size by Application
- 10.3.1 Asia Biobanking LIMS Software Market Size by Application (2021-2026)
- 10.3.2 Asia Biobanking LIMS Software Market Size by Application (2027-2032)
- 10.3.3 Asia Biobanking LIMS Software Market Share by Application (2021-2032)
- 10.4 Asia Biobanking LIMS Software Market Size by Country
- 10.4.1 Asia Biobanking LIMS Software Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Biobanking LIMS Software Market Size by Country (2021-2026)
- 10.4.3 Asia Biobanking LIMS Software Market Size by Country (2027-2032)
- 10.4.4 Asia Biobanking LIMS Software Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Biobanking LIMS Software Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Biobanking LIMS Software Market Size by Type
- 11.2.1 South America, Middle East & Africa Biobanking LIMS Software Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Biobanking LIMS Software Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Biobanking LIMS Software Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Biobanking LIMS Software Market Size by Application
- 11.3.1 South America, Middle East & Africa Biobanking LIMS Software Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Biobanking LIMS Software Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Biobanking LIMS Software Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Biobanking LIMS Software Market Size by Country
- 11.4.1 South America, Middle East & Africa Biobanking LIMS Software Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Biobanking LIMS Software Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Biobanking LIMS Software Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Biobanking LIMS Software Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst